coronavirus disease 2019 (COVID-19) pandemic. [1][2][3][4] Polymerase chain reaction (PCR) has been the gold standard for molecular tests. [5] However, its timeconsuming protocols and the need for laboratory infrastructure largely preclude it from point-of-care (POC) testing. [6,7] Isothermal amplification methods, such as loop-mediated isothermal amplification (LAMP), have emerged as an alternative to PCR and allow POC testing without the need for thermal cycling. [8] Although simple, LAMP is susceptible to non-template amplification and its simple readout (e.g., based on pH change) cannot distinguish template versus non-templated amplification, thus leads to false-positive results. [8][9][10][11][12] Previous efforts in reducing the non-template amplification focused on primer design, additives introduction (e.g., betaine), and closed-tube detection. [13][14][15] However, it is still difficult to prevent the non-template amplification caused by the formation of primer dimers, considering that a number of primers (up to 6) are used in LAMP assays and the potential contamination from isothermal conditions (e.g., water bath). [15] It is therefore important to develop techniques that can accurately identify the amplified sequences via an accessible detection scheme, in order to provide diagnostic platforms with simple readouts and high detection specificity and sensitivity.The ability to detect pathogens specifically and sensitively is critical to combat infectious diseases outbreaks and pandemics. Colorimetric assays involving loop-mediated isothermal amplification (LAMP) provide simple readouts yet suffer from the intrinsic non-template amplification. Herein, a highly specific and sensitive assay relying on plasmonic sensing of LAMP amplicons via DNA hybridization, termed as plasmonic LAMP, is developed for the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) RNA detection. This work has two important advances. First, gold and silver (Au-Ag) alloy nanoshells are developed as plasmonic sensors that have 4-times stronger extinction in the visible wavelengths and give a 20-times lower detection limit for oligonucleotides over Au counterparts. Second, the integrated method allows cutting the complex LAMP amplicons into short repeats that are amendable for hybridization with oligonucleotide-functionalized Au-Ag nanoshells. In the SARS-CoV-2 RNA detection, plasmonic LAMP takes ≈75 min assay time, achieves a detection limit of 10 copies per reaction, and eliminates the contamination from non-template amplification. It also shows better detection specificity and sensitivity over commercially available LAMP kits due to the additional sequence identification. This work opens a new route for LAMP amplicon detection and provides a method for virus testing at its early representation.